Patents by Inventor Gary Gilliland

Gary Gilliland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140206624
    Abstract: Compositions and methods for the treatment of leukemia by inhibiting FOXO signaling are described.
    Type: Application
    Filed: February 6, 2012
    Publication date: July 24, 2014
    Applicants: THE BRIGHAM AND WOMEN'S HOSPITAL, INC., THE GENERAL HOSPITAL CORPORATION
    Inventors: Stephen Matthew Sykes, David T. Scadden, Dwight Gary Gilliland
  • Publication number: 20130338092
    Abstract: This invention relates to high-throughput, semi-automated methods for identifying compounds that are effective in targeting leukemia stem cells, as well as compounds identified by those methods and uses thereof for treating leukemia.
    Type: Application
    Filed: August 16, 2013
    Publication date: December 19, 2013
    Inventors: Kimberly Hartwell, Malcolm A.S. Moore, David T. Scadden, Stuart L. Schreiber, Todd R. Golub, Benito Munoz, Benjamin L. Ebert, Andrew M. Stern, Peter G. Miller, D. Gary Gilliland, Anne Van Dyk Carpenter, David J. Logan, Joseph Negri, Nicola Tolliday, Alykhan Shamji, Siddhartha Mukherjee, Alison Stewart
  • Publication number: 20090286770
    Abstract: The present invention relates to the use of staurosporines derivatives for the preparation of a drug for the treatment of diseases involving ras or FGFR3 signalling pathways and l or c-fos transcription, especially for the curative and/or prophylactic treatment of myeloma or multiple Myeloma, and to a method of treating diseases involving ras or FGFR3 signalling pathways and/or c-fos transcription.
    Type: Application
    Filed: December 7, 2005
    Publication date: November 19, 2009
    Inventors: D. Gary Gilliland, James Douglas Griffin, Jing Chen, Kenneth C. Anderson
  • Patent number: 5213961
    Abstract: A process for quantitating nucleic acids species in a sample is described which comprises co-amplification of a competitive template with the sample template wherein the competitive template utilizes primers identical to those utilized by the sample template and wherein the competitive template is distinguishable from the sample template.
    Type: Grant
    Filed: August 31, 1989
    Date of Patent: May 25, 1993
    Assignee: Brigham and Women's Hospital
    Inventors: H. Franklin Bunn, Gary Gilliland, Kerry Blanchard, Steven Perrin